Effect of B-vitamin supplementation on stroke: A meta-analysis of randomized controlled trials

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Chi ^a   Chi, Feng Ling ^a   Xie, Tian Hao ^b   Zhou, Yu Hao ^a  

^a SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE; VITAMIN B GROUP;

ARTICLE; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; DRUG DOSE REGIMEN; DRUG EFFICACY; FOLLOW UP; HUMAN; INCIDENCE; META ANALYSIS; PRIMARY PREVENTION; PUBLISHING; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SEX RATIO; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; HOMOCYSTEINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE; VITAMIN B COMPLEX;

EID: 84896715135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081577     Document Type: Article

References (42)

1. Williams GR, Jiang JG, Matchar DB, Samsa GP (1999) Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 30: 2523-2528. doi:10.1161/01.STR.30.12.2523. PubMed: 10582972.
2. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases, I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104: 2746-2753. doi:10.1161/hc4601.099487. PubMed: 11723030. (Pubitemid 33108145)
3. Brattstrom LE, Hardebo JE, Hultberg BL (1984) Moderate homocysteinemia-a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 15: 1012-1016. doi:10.1161/01.STR.15.6.1012. PubMed: 6506111. (Pubitemid 15175240)
4. Lindgren A, Brattström L, Norrving B, Hultberg B, Andersson A et al. (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26: 795-800. doi:10.1161/01.STR.26.5.795. PubMed: 7740569.
5. Vollset SE, Refsum H, Tverdal A, Nygård O, Nordrehaug JE et al. (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 74: 130-136. PubMed: 11451728. (Pubitemid 32574920)
6. McNulty H, Pentieva K, Hoey L, Ward M (2008) Homocysteine, B-vitamins and CVD. Proc Nutr Soc 67: 232-237. doi:10.1017/S0029665108007076. PubMed: 18412997. (Pubitemid 351543405)
7. Heinz J, Kropf S, Domröse U, Westphal S, Borucki K et al. (2010) B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease : Results of a Randomized Controlled Trial. Circulation 121: 1432-1438. doi:10.1161/CIRCULATIONAHA. 109.904672. PubMed: 20231532.
8. ASFAST Study Group (2006) Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure A Multicenter, Randomized, Controlled Trial. J Am Coll Cardiol 47: 1108-1116. doi:10.1016/j.jacc.2005.10.064. PubMed: 16545638.
9. DIVINe Study Group (2010) Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy A Randomized Controlled Trial. JAMA 303: 1603-1609. doi:10.1001/jama.2010.490. PubMed: 20424250.
10. WAFACS Study Group (2008) Effect of Folic Acid and B-Vitamins on Risk of Cardiovascular Events and Total Mortality among Women at High Risk for Cardiovascular Disease: A Randomized Trial. JAMA 299: 2027-2036. doi:10.1001/jama.299.17.2027. PubMed: 18460663.
11. Veterans Affairs Site Investigators (2007) Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease A Randomized Controlled Trial. JAMA 298: 1163-1170. doi:10.1001/jama.298.10.1163. PubMed: 17848650.
12. VISP Trial Investigators (2004) Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA 291: 565-575. doi:10.1001/jama.291.5.565. PubMed: 14762035.
13. SU FOL.OM3; Collaborative Group (2010) Effects of B vitamins and omega 3 fatty acids on Cardiovascular diseases: a randomised placebo controlled trial. BMJ 341:c6273.
14. SEARCH Collaborative Group (2010) Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors A Randomized Trial. JAMA 303: 2486-2494. doi:10.1001/jama.2010.840. PubMed: 20571015.
15. Polyp Prevention Study Group (2007) Folic Acid for the Prevention of Colorectal Adenomas A Randomized. Clinical Trials - JAMA 297: 2351-2359.
16. NORVIT Trial Investigators (2006) Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. N Engl J Med 354: 1578-1588. doi:10.1056/NEJMoa055227. PubMed: 16531614.
17. FAVORIT Study Group (2011) Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. Circulation 123: 1763-1770. doi:10.1161/CIRCULATIONAHA.110.000588. PubMed: 21482964.
18. Righetti M, Serbelloni P, Milani S, Ferrario G (2006) Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients. Blood Purif 24: 379-386. doi:10.1159/000093680. PubMed: 16755160. (Pubitemid 44215183)
19. WENBIT Study Group (2008) Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography A Randomized Controlled Trial. JAMA 300: 795-804. doi:10.1001/jama.300.7.795. PubMed: 18714059.
20. Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS et al. (2004) Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease. J Am Soc Nephro 115: 420-426. PubMed: 14747389. (Pubitemid 38140783)
21. VITATOPS Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9: 855-865. doi:10.1016/S1474-4422(10)70187-3. PubMed: 20688574.
22. Liem A, Reynierse-Buitenwerf GH, Ah Zwinderman Jukema JW, van Veldhuisen DJ (2005) Secondary prevention with folic acid: results of the Goes extension study. Heart 91: 1213-1214. doi:10.1136/hrt.2004.035030. PubMed: 16103563. (Pubitemid 41192405)
23. The Linxian Nutrition Intervention Trial Group (1996) Lowered Risks of Hypertension and Cerebrovascular Disease after itamin/Mineral Supplementation. Am J Epidemiol 143: 658-664. doi:10.1093/oxfordjournals.aje.a008798. PubMed: 8651227.
24. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006) Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease. N Engl J Med 354 (1567-77)
25. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine 6: e1000097.
26. Jadad AR, Moore RA, Carroll D (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12. doi:10.1016/S0197-2456(96)90740-0. PubMed: 8721797. (Pubitemid 26120810)
27. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833. (Pubitemid 17189972)
28. Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects metaanalysis in decision models. Med Decis Making 25: 646-654. doi:10.1177/0272989X05282643. PubMed: 16282215. (Pubitemid 41667133)
29. Deeks JJ, Higgins JPT, Altman DG (2008) Analyzing data and undertaking meta-analyses. In: J HigginsS Green Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford, UK: The Cochrane Collaboration: chap 9
30. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. doi:10.1136/bmj.327.7414.557. PubMed: 12958120. (Pubitemid 37088507)
31. Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573. doi:10.1002/sim.1187. PubMed: 12111920. (Pubitemid 34746063)
32. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563. (Pubitemid 27387172)
33. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446. PubMed: 7786990.
34. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y et al. (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369: 1876-1882. doi:10.1016/S0140-6736(07)60854-X. PubMed: 17544768. (Pubitemid 46829358)
35. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML et al. (2012) Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr 31: 448-454. doi:10.1016/j.clnu.2011.01.003. PubMed: 22652362.
36. Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E (2009) Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 40: 1365-1372. doi:10.1161/STROKEAHA.108.529503. PubMed: 19228852.
37. Ji Y, Tan S, Xu Y, Chandra A, Shi C et al. (2013) Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: A meta-analysis. Neurology 81: 1-10. doi:10.1212/WNL.0b013e3182983129.
38. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057. doi:10.1001/jama.274.13.1049. PubMed: 7563456.
39. David Spence J, Stampfer MJ (2011) Understanding the Complexity of Homocysteine Lowering With Vitamins The Potential Role of Subgroup Analyses. JAMA; 306: 2610-2611. doi:10.1001/jama.2011.1834. PubMed: 22187282.
40. He K, Merchant A, Rimm EB, Willett WC, Ascherio A (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35: 169-174. PubMed: 14671243. (Pubitemid 38057614)
41. Larsson SC, Männistö S, Virtanen MJ, Virtamo J (2008) Folate, vitamin B6, vitamin B12, and methionine intakes and risk of stroke subtypes in male smokers. Am J Epidemiol;167: 954-961. doi:10.1093/aje/kwm395. PubMed: 18270369. (Pubitemid 351521737)
42. Al-Delaimy WK, Rexrode KM, Hu FB, Albert CM, Manson JE (2004) Folate intake and risk of stroke among women. Stroke; 35: 1259-1263. doi:10.1161/01.STR.0000127813.12854.9c. PubMed: 15105514. (Pubitemid 38697438)